Lina

Name: Lina
Brand: Lina
Price: 26500.00 USD
Availability: InStock

MRRdeals Score · 39/100

Health & Fitness·Founded Jan 2026·Revenue rank #2,461

🆕 New listing

Share on X

View on TrustMRR

Share on X

MRR

$430/mo-6.3%

Asking

$26.5K

$MRRdeals score

39/100

What this SaaS is

Tracks GLP-1 medication use, symptoms, weight-loss progress, and habit-building for people using weight-loss medication.

SubscriptionA consumer health app operator with experience in subscription growth, app-store distribution, and responsible support for medication users.

Key features

Medication tracking
Symptom tracking
Progress tracking
Habit-building tools

Things to scrutinise

Founded <12mo ago— Less than 12 months of operating history. Retention is unproven.
Regulatory risk niche— Trading / gambling / crypto / medical. One letter from a regulator can shut it down.

Numbers that matter

MRR

$430/mo

Revenue 30d

$272

Cash actually collected

All-time

$4.8K

Active subscriptions

127

Total customers

—

Not reported by TrustMRR

Growth 30d

-6.3%

Profit margin

41%

Multiple

8.1x

Asking / ARR

Payback

150.2 mo

At current margin

At a glance

Founded

10 mo ago

Listed

2d ago · fresh

Payments

Revenuecat

Audience

B2C

Mobile app

App Store Google Play4.4(32 ratings)Version 2.0.12

Apple and Google keep 15–30% of subscriptions: check whether the revenue and margin above are before or after the store commission, and plan the transfer of the app and its subscriptions through App Store Connect or Google Play.

Websiteapps.apple.com/us/app/lina-all-in-one-glp-1-app/id6756721409?uo=4

Tech stack

frontend

exposwifttailwindcss

backend

supabase

Marketing channels

organic

app store optimizationblogseo

social

instagramreddit

Score breakdown

How the composite score above splits across seven independent signals. Each axis is graded 0-100. Hover for details.

Value15/100

Payback at the stated margin, asking multiple vs the category median, and profit margin. The heaviest axis: what you pay for what it earns.

Growth12/100

Revenue trend over the last ~90 days from our daily snapshots (30-day figure when history is short), capped so one spike can't dominate, minus a penalty for erratic revenue.

Traction56/100

Paying customers, revenue scale and traffic (log scales), plus live-site health (reachable pricing page, core pages, maintained site).

Moat44/100

AI-disruption risk, organic search presence, recurring B2B revenue; penalties for thin AI wrappers and no-code lock-in.

Operability56/100

How turnkey the takeover is: diversity of marketing channels, Merchant-of-Record status, team.

Risk72/100

Higher = safer. Business age, breadth of the customer base (concentration risk), recurring vs one-off revenue, known payment provider.

Market65/100

Structured market read across TAM, saturation, 3-year trend, and hype cycle, blended with our category momentum signal.

Market read

TAM
mid
GLP-1 use is expanding rapidly, but the app serves a medication-specific slice of the broader consumer health market.
Saturation
growing
Dedicated GLP-1 companion apps are emerging, while established weight-loss and medication-tracking apps already compete for users.
3y trend
growing
Rising GLP-1 adoption is increasing demand for symptom, medication, and habit tracking.
AI disruption
vulnerable
Tracking and habit guidance are easy to reproduce, though medication-specific workflows and user trust add some defensibility.
Hype cycle
mainstream
GLP-1 products have entered mainstream awareness, with consumer adoption extending beyond early adopters.